SAN DIEGO, Dec. 9, 2016 /PRNewswire/ -- aTyr Pharma, Inc.
(Nasdaq: LIFE), a biotherapeutics company engaged in the discovery
and development of Physiocrine-based therapeutics to address
severe, rare diseases, today announced that senior management will
participate in a fireside chat at the upcoming BMO Prescriptions
for Success Healthcare Conference at the InterContinental Barclay
Hotel in New York City on
Wednesday, December 14, 2016, at
4:20 p.m. ET.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development
of innovative medicines for patients suffering from severe rare
diseases using its knowledge of Physiocrine biology, a newly
discovered set of physiological modulators. The Company's lead
candidate, Resolaris™, is a potential first-in-class intravenous
protein therapeutic for the treatment of rare myopathies with an
immune component. Resolaris is currently in a Phase 1b/2 trial in
adult patients with limb-girdle muscular dystrophy 2B (LGMD2B or
dysferlinopathies) or FSHD and a Phase 1b/2 trial in patients with
an early onset form of FSHD. In addition, Resolaris is currently
being evaluated in two Phase 1b/2 long-term safety extension
studies, the first in patients with adult FSHD and the second in
patients with LGMD2B, adult FSHD or early onset FSHD. To protect
this pipeline, aTyr has built an intellectual property estate
comprising over 80 issued or allowed patents and over 230 pending
patent applications that are owned or exclusively licensed by aTyr,
including over 300 potential Physiocrine-based protein
compositions. aTyr's key programs are currently focused on severe,
rare diseases characterized by immune dysregulation for which there
are currently limited or no treatment options. For more
information, please visit http://www.atyrpharma.com.
Contact:
Mark Johnson
Sr. Director, Investor Relations
mjohnson@atyrpharma.com
858-223-1163
Logo -
http://photos.prnewswire.com/prnh/20120809/MM55538LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/atyr-pharma-to-present-at-the-bmo-prescriptions-for-success-healthcare-conference-300375951.html
SOURCE aTyr Pharma, Inc.